Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

international flavors & fragrances inc. - IFF

IFF

Close Chg Chg %
89.78 1.03 1.15%

Closed Market

90.81

+1.03 (1.15%)

Volume: 1.64M

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Trade Now

Company Overview: international flavors & fragrances inc. - IFF

IFF Key Data

Open

$90.04

 Day Range

89.27 - 90.90

52 Week Range

72.94 - 106.77

 Market Cap

$22.96B

Shares Outstanding

255.68M

 Public Float

230.17M

Beta

1.24

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$9.09

Yield

223.88%

 Dividend

$0.40

EX-DIVIDEND DATE

Dec 20, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.67M

  

IFF Performance

1 Week
 
 4.23%
 
1 Month
 
 -11.50%
 
3 Months
 
 -10.29%
 
1 Year
 
 20.14%
 
5 Years
 
 -35.88%
 

IFF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 23
Full Ratings ➔

About international flavors & fragrances inc. - IFF

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

IFF At a Glance

International Flavors & Fragrances, Inc.
521 West 57th Street
New York, New York 10019-2960
Phone 1-212-765-5500 Revenue 11.48B
Industry Food: Specialty/Candy Net Income -2,565,000,000.00
Sector Consumer Non-Durables Employees 21,500
Fiscal Year-end 12 / 2024
View SEC Filings

IFF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.799
Price to Book Ratio 1.415
Price to Cash Flow Ratio 14.348
Enterprise Value to EBITDA 15.607
Enterprise Value to Sales 2.682
Total Debt to Enterprise Value 0.351

IFF Efficiency

Revenue/Employee 533,906.977
Income Per Employee -119,302.326
Receivables Turnover 5.49
Total Asset Turnover 0.346

IFF Liquidity

Current Ratio 1.675
Quick Ratio 1.015
Cash Ratio 0.189

IFF Profitability

Gross Margin 26.126
Operating Margin 7.239
Pretax Margin -21.936
Net Margin -22.345
Return on Assets -7.728
Return on Equity -15.885
Return on Total Capital -10.085
Return on Invested Capital -9.663

IFF Capital Structure

Total Debt to Total Equity 74.074
Total Debt to Total Capital 42.553
Total Debt to Total Assets 34.938
Long-Term Debt to Equity 67.388
Long-Term Debt to Total Capital 38.712
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for International Flavors & Fragrances Inc. - IFF

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
5.08B 11.66B 12.44B 11.48B
Sales Growth
-1.09% +129.26% +6.73% -7.73%
Cost of Goods Sold (COGS) incl D&A
3.20B 8.65B 9.02B 8.48B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
325.36M 1.16B 1.18B 1.14B
Depreciation
132.75M 424.00M 452.00M 462.00M
Amortization of Intangibles
192.61M 732.00M 727.00M 680.00M
COGS Growth
-0.86% +170.88% +4.17% -5.94%
Gross Income
1.89B 3.00B 3.42B 3.00B
Gross Income Growth
-1.47% +58.86% +14.10% -12.41%
Gross Profit Margin
+37.16% +25.75% +27.52% +26.13%
2020 2021 2022 2023 5-year trend
SG&A Expense
1.17B 2.11B 2.28B 2.17B
Research & Development
356.86M 629.00M 603.00M 636.00M
Other SG&A
808.68M 1.48B 1.67B 1.53B
SGA Growth
+2.69% +80.95% +7.97% -4.79%
Other Operating Expense
- - - -
-
Unusual Expense
149.33M 309.00M 2.47B 2.96B
EBIT after Unusual Expense
574.19M 583.00M (1.32B) (2.12B)
Non Operating Income/Expense
(1.88M) 59.00M 33.00M (14.00M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
130.94M 288.00M 336.00M 380.00M
Interest Expense Growth
-4.67% +119.94% +16.67% +13.10%
Gross Interest Expense
130.94M 288.00M 336.00M 380.00M
Interest Capitalized
- - - -
-
Pretax Income
441.37M 354.00M (1.63B) (2.52B)
Pretax Income Growth
-20.82% -19.80% -559.04% -54.95%
Pretax Margin
+8.68% +3.04% -13.06% -21.94%
Income Tax
74.00M 75.00M 239.00M 45.00M
Income Tax - Current - Domestic
(7.66M) 8.00M 151.00M 55.00M
Income Tax - Current - Foreign
149.38M 303.00M 325.00M 359.00M
Income Tax - Deferred - Domestic
(10.00M) (155.00M) (188.00M) (81.00M)
Income Tax - Deferred - Foreign
(57.72M) (81.00M) (49.00M) (288.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
(1.00M) (2.00M) 3.00M 2.00M
Consolidated Net Income
366.37M 277.00M (1.86B) (2.56B)
Minority Interest Expense
2.34M 9.00M 7.00M 4.00M
Net Income
364.03M 268.00M (1.87B) (2.56B)
Net Income Growth
-19.60% -26.38% -797.01% -37.31%
Net Margin Growth
+7.16% +2.30% -15.02% -22.35%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
364.03M 268.00M (1.87B) (2.56B)
Preferred Dividends
- - - -
-
Net Income Available to Common
364.03M 268.00M (1.87B) (2.56B)
EPS (Basic)
3.2456 1.1029 -7.3255 -10.0588
EPS (Basic) Growth
-19.74% -66.02% -764.20% -37.31%
Basic Shares Outstanding
112.16M 243.00M 255.00M 255.00M
EPS (Diluted)
3.2036 1.1029 -7.3255 -10.0588
EPS (Diluted) Growth
-19.83% -65.57% -764.20% -37.31%
Diluted Shares Outstanding
113.63M 243.00M 255.00M 255.00M
EBITDA
1.05B 2.05B 2.33B 1.97B
EBITDA Growth
-5.12% +95.26% +13.57% -15.18%
EBITDA Margin
+20.63% +17.57% +18.70% +17.19%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 105.737
Number of Ratings 23 Current Quarters Estimate 0.82
FY Report Date 12 / 2024 Current Year's Estimate 4.191
Last Quarter’s Earnings 1.04 Median PE on CY Estimate N/A
Year Ago Earnings 3.34 Next Fiscal Year Estimate 4.592
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 13 6 18 18
Mean Estimate 0.82 1.21 4.19 4.59
High Estimates 1.00 1.35 4.48 5.30
Low Estimate 0.68 1.12 4.02 3.95
Coefficient of Variance 11.76 7.42 3.00 6.70

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 9 9
OVERWEIGHT 3 3 3
HOLD 7 10 11
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Overweight

Insider Actions for International Flavors & Fragrances Inc. - IFF

Date Name Shares Transaction Value
Oct 4, 2024 Glenn Robert Richter CFO 32,171 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 4, 2024 Glenn Robert Richter CFO 27,049 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $103.12 per share 2,789,292.88
Oct 4, 2024 Glenn Robert Richter CFO 20,392 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 3, 2024 Margarita Paláu-Hernández Director 1,543 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 8, 2024 Kevin O'Byrne Director 1,933 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Deborah Borg EVP, Chief HR and D&I Officer 17,188 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Deborah Borg EVP, Chief HR and D&I Officer 16,475 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $86.64 per share 1,427,394.00
May 8, 2024 Deborah Borg EVP, Chief HR and D&I Officer 42,897 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Simon W. Herriott Pres. Health & Bioscience 10,625 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Simon W. Herriott Pres. Health & Bioscience 10,132 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $86.64 per share 877,836.48
May 8, 2024 Roger W. Ferguson Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Roger W. Ferguson Director 2,625 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Kevin O'Byrne Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Kevin O'Byrne Director 1,715 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $86.64 per share 148,587.60
May 8, 2024 Christina A. Gold Director 10,840 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Mark J. Costa Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Mark J. Costa Director 2,139 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 De Mendonca Ana Paula Teles President, Scent N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Carol Anthony Davidson Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 8, 2024 Carol Anthony Davidson Director 1,926 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

International Flavors & Fragrances Inc. in the News